Exact Sciences Corporation Stock Mexican S.E.
Stocks
EXAS *
US30063P1057
Biotechnology & Medical Research
| Market Cap | 20.03B 350B 17.56B 16.27B 14.97B 28.31B 1,917B 28.86B 194B 76.05B 941B 75.2B 73.56B 3,251B | P/E 2024 |
-10.1x | P/E 2025 | -92.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.6B 378B 18.94B 17.54B 16.14B 30.53B 2,067B 31.13B 209B 82.01B 1,015B 81.1B 79.32B 3,506B | EV / Sales 2024 |
4.4x | EV / Sales 2025 | 6.42x |
| Free-Float |
98.24% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Exact Sciences Corporation
| 1 day | -15.23% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.23% | +9.18% | - | - | 20.03B | |
| +0.90% | -0.89% | +112.26% | +101.54% | 4.55B | |
| -0.19% | -2.23% | +77.83% | +185.60% | 3.37B | |
| +1.08% | +1.16% | -26.22% | -38.59% | 2.05B | |
| -4.49% | -3.58% | +116.04% | -47.40% | 1.89B | |
| +0.88% | -1.03% | +42.87% | +184.47% | 1.47B | |
| +4.43% | +7.80% | +132.97% | -50.51% | 898M | |
| -1.90% | -3.07% | -11.78% | +39.46% | 880M | |
| +2.24% | +3.33% | -0.46% | - | 487M | |
| -2.32% | -5.43% | -38.25% | -19.55% | 483M | |
| Average | -1.46% | -0.55% | +45.03% | +44.38% | 1.79B | |
| Weighted average by Cap. | -8.43% | -0.35% | +67.91% | +75.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.76B 48.27B 2.42B 2.24B 2.06B 3.9B 264B 3.98B 26.71B 10.48B 130B 10.36B 10.13B 448B | 3.25B 56.82B 2.85B 2.64B 2.43B 4.59B 311B 4.68B 31.44B 12.33B 153B 12.19B 11.93B 527B |
| Net income | -1.03B -18B -902M -836M -769M -1.45B -98.47B -1.48B -9.96B -3.91B -48.36B -3.86B -3.78B -167B | -208M -3.64B -182M -169M -155M -294M -19.9B -300M -2.01B -790M -9.77B -781M -764M -33.75B |
| Net Debt | 1.74B 30.41B 1.52B 1.41B 1.3B 2.46B 166B 2.5B 16.82B 6.6B 81.68B 6.53B 6.38B 282B | 1.57B 27.47B 1.38B 1.28B 1.17B 2.22B 150B 2.26B 15.2B 5.96B 73.8B 5.9B 5.77B 255B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
